Advanced breast diffusion-weighted imaging: what are the next steps? A proposal from the EUSOBI International Breast Diffusion-weighted Imaging working group.
Eur Radiol
2024
Bone Marrow Adiposity Alterations in Postmenopausal Women With Type 2 Diabetes Are Site-Specific.
J Endocr Soc
2024
8
11
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol
2024
42
4
410-420
LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICALTRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?
Leuk Res
2023
128 Suppl S
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial.
Br J Cancer
2024
131
2
299-304
Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial.
J Clin Oncol
2024
42 Suppl 17_SUPPL
17_SUPPL
LBA4001-LBA4001
Safety and efficacy of the Amplatzer™ Trevisio™ intravascular delivery system: Post-approval study results.
Arch Cardiovasc Dis
2023
116
12
580-589
When Does a Calcium Score Equate to Secondary Prevention?: Insights From the Multinational CONFIRM Registry.
JACC Cardiovasc Imaging
2023
16
9
1181-1189
What do patients' efficacy and tolerability ratings of acute migraine medication tell us? Cross-sectional data from the DMKG Headache Registry.
Cephalalgia
2023
43
5
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).
Front Oncol
2023
13